当前位置：首页 > 文献互助 > 互助详情

{Monographs}[USP] Pimecrolimus复制

用户LvjyCPGyrapA 1个月前 121 50 已完结

1. 系统已在2026-08-06 10:36:15对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

来源:美国药典复制

版本:USPNF 2026 Issue 6复制

其他信息:

上一篇：Repurposing FDA-Approved Drugs as Nav1.7 Channel Modulators: An Integrated Structure-Based Virtual Screening and Molecular Dynamics Study

下一篇：Vitamin C attenuates primate bone marrow aging at the molecular and progenitor level

互助时间线

2026-08-03 10:05:19 [完结求助]

系统完结了求助, 已自动确认了用户c-ARPKWB-3lY应助的文件是正确的, 求助状态变成 已完结

2026-07-30 10:36:15 [上传文件]

用户c-ARPKWB-3lY上传了文件(pdf 235.23 KB), 求助状态变成 待确认

2026-07-29 10:05:19 [发起求助]

最新发布的求助

Ag Nanocluster-Triggered Lattice Oxygen Activation in Amorphous Sulfide Matrices for Superior Oxygen Evolution 3小时前
Anchoring Atomic Ag in Ordered Oxygen Vacancies for High-Performance Anode-Free Lithium Metal Batteries 3小时前
ESG and Firm Performance: Non-linear Dynamics and Bidirectional Causality in Pharmaceutical Industry 4小时前
FUT-175の血液透析用抗凝固薬としての有用性について‐多施設共同試験 5小时前
Bone Fragility in Diabetes and its Management: A Narrative Review 5小时前
Examining the Interplay of Grit, Classroom Emotions, and Willingness to Communicate Among Chinese as a Second Language Learners: A Structural Equation Modeling Approach 5小时前
Preclinical development of a next generation antibody drug conjugate (ADC) targeting B7-H3 for treatment of solid tumors 6小时前
Abstract 6304: Preclinical development of a next generation antibody drug conjugate (ADC) targeting B7-H3 for treatment of solid tumors 6小时前
The predictive roles of enjoyment, anxiety, willingness to communicate on students’ performance in English public speaking classes 6小时前
FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models 6小时前
机械强度高且柔韧性好的氮化物陶瓷纳米纤维可实现先进的热管理 9小时前
Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies 9小时前

wispass工作室 Copyright © 蜀ICP备20005939号-4 www.wispass.com